Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

$RLMDPress releaseJul 16, 2026, 7:05 AM ETRead the release

Relmada Therapeutics announced it will hold a conference call on August 6, 2026, to discuss its second quarter financial results. The webcast is scheduled to begin at 4:30 PM ET, with replay access available on the company's investor relations website.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.